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Abstract
Introduction: Behavioral undercontrol is a well- established risk factor for substance 
use disorder, identifiable at an early age well before the onset of substance use. 
However, the biological mechanistic structure underlying the behavioral undercon-
trol/substance use relationship is not well understood. The enzyme catechol O- 
methyltransferase (COMT) catabolizes dopamine and norepinephrine in the prefrontal 
cortex and striatum, brain regions involved in behavioral control. The goal of this work 
was to investigate the association between genetic variation in COMT functioning and 
fronto- striatal brain functioning during successful inhibitory control, a critical aspect 
of behavioral control.
Methods: Participants were 65 (22 female) 7–12 year olds who were genotyped for 
the functional COMT Val158Met (rs4680) single- nucleotide polymorphism and under-
went functional magnetic resonance imaging while performing a go/no- go task. The 
majority of the sample (80%) had at least one parent with a history of alcohol use dis-
order and were thus at heightened risk for substance use disorders.
Results: There was a significant main effect of genotype on brain activation in left and 
right putamen during successful versus failed inhibition and in right inferior frontal 
gyrus/insula during successful inhibition versus baseline. Follow- up tests revealed that 
Met homozygotes had greater activation in each region relative to Val homozygotes.
Conclusions: These results are relevant for understanding how specific genes influ-
ence brain functioning related to underlying risk factors for substance use disorders 
and other disinhibitory psychopathologies.
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1  | INTRODUCTION
Substance use initiation by age 13 is associated with greater risk of 
developing a substance use disorder (SUD) (Grant & Dawson, 1997) 
and can have a negative impact on academic achievement, family and 
peer relationships, and psychosocial maturation (Schulenberg, Bryant, 
& O’Malley, 2004). Understanding the biological risk structure that 
drives early substance use onset may aid in the development of more 
effective prevention strategies to reduce the incidence and impact of 
SUD.
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One of the most robust risk factors for SUD, identifiable prior to the 
initiation of substance use, is behavioral undercontrol (McGue, Iacono, 
Legrand, Malone, & Elkins, 2001; Zucker, Heitzeg, & Nigg, 2011). Poor 
inhibitory control has been proposed as an underlying cognitive mech-
anism contributing to behavioral undercontrol (Zucker et al., 2011). At 
the neural level, the mesolimbic dopaminergic pathway is fundamen-
tally related to these operations (Dalley, Mar, Economidou, & Robbins, 
2008; Diergaarde et al., 2008). The dopamine system undergoes dra-
matic change during adolescence, concomitant with substance use 
initiation and escalation (Luciana, Wahlstrom, Porter, & Collins, 2012; 
Spear, 2011). It is also centrally related to the reinforcement poten-
tial of drugs of abuse (Everitt & Robbins, 2005; Robinson & Berridge, 
2000), and has been implicated in pre- existing vulnerability to addic-
tion (McBride & Li, 1998; Volkow et al., 2002). An emerging literature 
describes the impact of dopaminergic genetic variation on brain func-
tioning during inhibitory control in healthy young adults (Cummins 
et al., 2012) and typically developing adolescents (Braet et al., 2011).
An important modulator of dopamine activity in the prefrontal cor-
tex and striatum is the enzyme catechol O- methyltransferase, which 
catabolizes dopamine and norepinephrine (Chen et al., 2004). A func-
tional valine (Val) to methionine (Met) substitution at codon 158 in the 
gene that codes for catechol O- methyltransferase (COMT Val158Met; 
rs4680) results in a 3–4 fold enzymatic activity increase and concom-
itant synaptic dopamine reduction in individuals homozygous for the 
Val allele (Chen et al., 2004). Studies of healthy youth (ages 8–14) have 
found the COMT Met allele to be associated with better inhibitory con-
trol (Diamond, Briand, Fossella, & Gehlbach, 2004), particularly in males 
(Barnett et al., 2007). A recent large- scale study of healthy adolescents 
(mean age 14.4; White et al., 2014) found a COMT × sex interaction in 
the presupplementary motor area during stop- signal inhibitory control, 
with male Val homozygotes showing the highest brain activity relative 
to the other two male genotypes; in females, however, this pattern was 
not observed, supporting other evidence that sex moderates the effects 
of COMT on brain activity (reviewed in Harrison & Tunbridge, 2008).
This study sought to better understand the association between 
the COMT Val158Met polymorphism and brain activity during inhibitory 
control prior to significant substance use in males and females at high 
risk for SUD (N = 65). Participants were 7–12 years old with minimal 
history of substance use. Based on previous work (Barnett et al., 2007; 
Diamond et al., 2004), we expected to find better inhibitory control per-
formance among those with at least one Met allele as well as greater 
brain activity during inhibitory control in frontal and striatal areas among 
Val homozygotes. In light of sex- related findings from prior studies, we 
also expected effects to be stronger in males than in females.
2  | MATERIAL AND METHODS
2.1 | Participants
Participants were 65 right- handed youth1 (22 female), aged 7.8–
12.9 years at the time of the fMRI scan (M = 10.4, SD = 1.17). They 
were recruited from the Michigan Longitudinal Study (MLS; Zucker, 
Ellis, Fitzgerald, Bingham, & Sander, 1996; Zucker et al., 2000), an on-
going, multiwave study of community- recruited families with and with-
out parental alcohol use disorder. Eighty percent of participants in the 
current sample had at least one parent with an alcohol use disorder. 
MLS assessments are conducted every three years starting when the 
children are age 3–5; adolescents and young adults are also assessed 
every year from age 11–26. Families were excluded during MLS re-
cruitment if the target child displayed evidence of fetal alcohol effects 
or the mother reported drinking during pregnancy. Exclusionary fetal 
alcohol characteristics included prenatal or postnatal growth retarda-
tion or both, central nervous system involvement, and characteristic 
facial dysmorphology (Loukas, Fitzgerald, Zucker, & von Eye, 2001; 
Sokol & Clarren, 1989). Full details on assessment and data collection 
in the MLS can be found elsewhere (Zucker et al., 2000).
For this study, participants were excluded if they had: neurolog-
ical, acute, or chronic medical illness; current, active Axis I disorder 
(not including past mood disorder or current or past anxiety disorder, 
conduct disorder, or ADHD); current or recent (within 6 months) treat-
ment with centrally active medications; MRI contraindications such 
as metal implants or claustrophobia; IQ <70; or history of psychosis 
in first- degree relatives. Participants who were taking medication for 
ADHD were asked to abstain at least 48 hr before the MRI scan. See 
Table 1 for demographic and psychometric variables.
Parents/guardians of participants provided written informed con-
sent and participants provided written informed assent. Study ma-
terials and procedures were approved by the University of Michigan 
Medical School Institutional Review Board.
2.2 | Measures
2.2.1 | Genotypes
COMT Val158Met (rs4680) was genotyped by a 5’ exonuclease al-
lelic discrimination TaqMan assay, provided by Applied Biosystems 
from the Drug Metabolism panel (Life Technologies, Grand Island, 
NY, USA) and allelic discrimination analysis was performed using the 
software SDS v2.2.2 (Applied Biosystems, Foster City, CA, USA). This 
SNP is part of the Illumina addiction biology SNP array designed by 
Hodgkinson et al. (2008). The panel includes SNPs from 130 candi-
date genes for alcoholism, addictions, and disorders of mood and anxi-
ety and is genotyped using the Illumina GoldenGate platform. About 
half of the larger overall MLS sample was genotyped by both the 
Taqman assay and the Illumina Addiction panel, and no discrepancies 
were observed in >200 samples. There was no significant deviation 
from Hardy–Weinberg equilibrium in either the overall or the fMRI 
subsample.
2.2.2 | Psychometric measures
The school age Child Behavior Checklist (CBCL; Achenbach & 
Rescorla, 2001) was used to assess externalizing (e.g., aggressive, rule- 
breaking) and internalizing (e.g., anxious, depressive) symptomology, 1A subset of these participants (n = 50) is the same as those from Hardee et al., 2014.
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as reported by parents. The Wechsler Intelligence Scale for Children 
(WISC- III; Wechsler, 1991) was used to assess full- scale IQ. Family 
history of AUD was defined as follows: A subject was considered 
family history positive (FH+) if one or both parents ever had a diag-
nosis of alcohol abuse or dependence, according to Diagnostic 
and Statistical Manual of Mental Disorders, 4th Edition (DSM- IV; 
American Psychiatric Association, 1994) criteria; if neither parent met 
these criteria the subject was considered family history negative (FH−). 
In addition, family history of AUD during the child’s lifetime was also 
specified. For diagnoses (e.g., ADHD, major depressive disorder, con-
duct disorder), the computerized Diagnostic Interview Schedule for 
Children (C- DISC; Shaffer, Fisher, Lucas, Dulcan, & Schwab- Stone, 
2000) was given and diagnoses were tallied based on DSM- IV criteria.
Substance use was assessed every three years between ages 6 and 
10 with a Health and Daily Living Questionnaire as part of the regular 
MLS assessment schedule. Questions covered use of marijuana, alcohol 
TABLE  1 Demographic and psychometric variables
Met/Met Val/Met Val/Val Total Sample Test
n 11 34 20 65
Demographic data
Sex (M/F) 8/3 22/12 13/7 43/22 p = .940a
Age at Scan: Mean (SD) 10.4 (1.08) 10.2 (1.22) 10.6 (1.14) 10.4 (1.17) F(2, 62) = 0.73 
p = .485
Race and Ethnicity (%)
Caucasian 13.8 27.7 18.5 60.0 p = .124a
Hispanic 0.0 10.8 0.0 10.8
African American 1.5 10.8 6.2 18.5
Biracial 1.5 3.1 6.2 10.8
Parental AUD (FH+/FH−)
Ever 8/3 26/8 18/2 52/13 p = .377a
In Child’s Lifetime 6/5 22/12 13/7 41/24 p = .883a
Substance Useb (Yes/No) 4/6 8/26 6/14 18/46 p = .554a
IQ: Mean (SD)c 101.7 (9.70) 102.4 (12.02) 103.8 (16.00) 102.7 (12.93) F(2, 59) = 0.11 
p = .897
Symptomology: Mean (SD)
CBCL Externalizing 6.6 (5.80) 10.5 (8.91) 7.0 (5.09) 8.7 (7.56) F(2, 62) = 1.93 
p = .154
CBCL Internalizing 3.8 (3.07) 7.7 (6.94) 5.3 (3.83) 6.3 (5.75) F(2, 62) = 2.37 
p = .102
DSM- IV lifetime diagnosis (count)
ADHD, any type 0 5 3 8 p = .536a
Generalized Anxiety Disorder 0 0 0 0 –
Major Depression Disorder 0 0 0 0 –
Oppositional Defiant Disorder 1 4 2 7 p = 1.000a
Conduct Disorder 0 0 1 1 p = .477a
Motion parameters: Mean (SD)
Translation (mm)d 0.046 (0.027) 0.035 (0.018) 0.031 (0.013) 0.036 (0.019) F(2, 62) = 2.33 
p = .106
Rotation (degrees)d 0.053 (0.031) 0.039 (0.021) 0.035 (0.016) 0.040 (0.022) F(2, 62) = 2.46 
p = .094
Runs excluded 0.09 (0.30) 0.18 (0.46) 0.40 (0.82) 0.23 (0.58) F(2, 62) = 1.33 
p = .271
SD, standard deviation; AUD, alcohol use disorder; FH+, alcohol use disorder in one or both parents; FH−, alcohol use disorder in neither parent; CBCL, 
Child Behavior Checklist (Achenbach & Rescorla, 2001); DSM- IV, Diagnostic and Statistical Manual of Mental Disorders IV (APA, 1994); ADHD, attention 
deficit hyperactivity disorder; mm, millimeters.
aFisher’s exact test.
bOne subject was missing drinking and drug history scores (Met/Met).
cThree subjects were missing IQ scores (1 Met/Met, 2 Val/Met).
dDefined as the mean difference from one volume to the next.
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(more than a sip), cigarettes, and other drugs. If relevant, the age at 
which use occurred and the quantity/frequency of use was recorded. 
Subsequent annual assessments (i.e., starting at age 11) involved the 
Drinking and Drug History Form for Children (Zucker & Fitzgerald, 
1994), which also covers age of use as well as quantity and frequency 
of alcohol, marijuana, nicotine, and other drug use. For the purposes of 
describing this study sample, substance use was dichotomized (yes/no).
2.3 | Stimuli and task
A go/no- go task (Durston, Thomas, Worden, Yang, & Casey, 2002; 
Hardee et al., 2014; Heitzeg, Nigg, Yau, Zucker, & Zubieta, 2010; 
Heitzeg et al., 2014) was used to probe response inhibition, or the 
ability to suppress a prepotent response. Participants were instructed 
to respond with a button press to target stimuli (all letters except “X”; 
p = .75) and to withhold the button press to nontarget stimuli (“X”; 
p = .25). Stimulus duration was 500 ms with an inter- stimulus interval 
of 3500 ms, during which a black screen with a white fixation cross 
was displayed. All responses that occurred within 3000 ms after 
stimulus onset were counted. A rapid mixed- trial event- related de-
sign was used. Participants completed 5 runs, each having 49 trials 
and lasting 3.5 min. Rates of false alarms (pressing the button for a 
nontarget stimulus; FAs), hits (pressing the button for a target stimu-
lus), misses (not pressing the button for a target stimulus), and correct 
rejections (not pressing the button for a nontarget stimulus; CRs) were 
recorded. Reaction times (measured from the beginning of stimulus 
presentation) to FAs and hits were also recorded. Finally, a measure 
of sensitivity, d’, was calculated as z(hit) – z(false alarm). Because the 
corresponding z- score is +∞ when hit rate is 1.0 (i.e., 100%), it is com-
mon practice to recalculate hit rate as 1 – 1/(2N), where N is the num-
ber of target stimuli (Macmillan & Kaplan, 1985; Stanislaw & Todorov, 
1999). This was done for the five participants with hit rates of 1.0 (3 
female, 2 male; 1 Met/Met, 1 Val/Met, 3 Val/Val). See Table 2 for task 
performance measures.
2.4 | fMRI data acquisition and statistical analysis
Whole- brain blood oxygen level- dependent (BOLD) functional images 
were acquired on a 3.0T GE Signa scanner (Milwaukee, WI, USA) using 
T2*- weighted single- shot combined spiral in/out sequences (Glover 
& Law, 2001) (TR 2000 ms, TE 30 ms, flip angle 90 degrees, field- of- 
view 200 mm, matrix size 64 × 64, slice thickness 4 mm, 29 slices). 
High- resolution anatomical T1 scans were also obtained for spatial 
normalization. Motion was minimized with foam padding around the 
head and instructing participants on the importance of keeping still.
Functional images were reconstructed using an iterative algo-
rithm (Noll, Fessler, & Sutton, 2005; Sutton, Noll, & Fessler, 2003) 
and motion corrected using FSL v5.0.2.2 (FMRIB, Oxford, UK). Runs 
exceeding 3 mm translation or 3° rotation were excluded2. Image 
preprocessing was completed using Statistical Parametric Mapping 
(SPM8 [RRID:SCR_007037]; Wellcome Institute of Cognitive 
Neurology, Oxford, UK). Functional images were spatially normalized 
to the Montreal Neurological Institute (MNI) template and smoothed 
with a 6 mm full- width at half- maximum (FWHM) smoothing kernel. 
Low- frequency noise was removed with a high- pass filter (128 s).
Image processing was done in SPM8. False alarms, correct rejec-
tions, and go trials were modeled separately with the standard hemo-
dynamic response function (event duration 4000 ms from stimulus 
onset), along with six realignment parameters and white matter sig-
nal intensity as nuisance variables. Our primary construct of interest 
was activation associated with successful inhibitory control. For each 
participant, images that represented the hemodynamic response as-
sociated with CRs versus FAs (i.e., successful vs. failed inhibition) and 
CRs versus implicit baseline were computed. Comparing CR activity 
with FA activity holds the stimulus (nontarget, or “no- go”) constant. In 
addition, an implicit baseline was used as opposed to target (i.e., “go”) 
trials because of the high frequency of target trials relative to the other 
event types (Devito et al., 2013).
At the group level, one- sample t- tests in SPM8 were used to de-
tect activation associated with correct rejections (i.e., CRs vs. FAs, 
CRs vs. baseline). We performed a whole- brain search at a family- wise 
error (FWE) corrected threshold of p < .05 and a voxel extent >25; 
significant clusters in prefrontal and striatal areas (i.e., those associ-
ated with COMT functioning) were identified, and beta values were 
TABLE  2 Go/no- go task performance measures
Met/Met Val/Met Val/Val
M F M F M F
Hits (%) 91.58 (13.78) 89.73 (2.39) 93.30 (10.97) 95.82 (2.87) 95.82 (4.60) 97.30 (3.22)
Hit RT (ms) 452.51 (48.82) 508.83 (28.69) 495.82 (103.29) 582.36 (255.58) 483.62 (109.08) 562.48 (90.61)
False Alarms (%) 57.40 (19.41) 30.57 (16.73) 48.34 (19.00) 42.63 (19.21) 50.38 (17.14) 29.54 (21.86)
False Alarm RT (ms) 436.35 (71.23) 459.97 (22.22) 443.00 (75.57) 499.44 (167.81) 435.15 (91.80) 488.11 (71.00)
d’ 1.54 (0.66) 1.83 (0.62) 1.84 (0.83) 2.08 (0.96) 1.93 (0.65) 2.80 (0.99)
M, male; F, female; RT, reaction time; ms, milliseconds; d’ is a measure of sensitivity and is calculated as z(hit) – z(false alarm).
Means with standard deviations in parentheses.
2The number of runs excluded was as follows: Met/Met = 1 (female = 1); Val/Met = 6 
(female = 2); Val/Val = 8 (female = 4). A 2 (sex)  × 3 (genotype) analysis of variance (ANOVA) 
on the number of runs excluded was not significant for the main effect of sex, main effect of 
genotype, or interaction (all ps > .270). Sex × genotype ANOVAs on average motion, defined 
as the mean difference from one volume to the next (calculated for rotation and translation, 
respectively), were also not significant for the main effect of sex, main effect of genotype, or 
iteraction (all ps > .148).
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extracted using MarsBaR (Brett, Anton, Valabregue, & Poline, 2002) 
and imported into IBM SPSS Statistics v.22 (IBM Corp, 2013) for fur-
ther analysis.
2.4.1 | Demographic, psychometric, and task 
performance measures
Fisher’s exact tests or one- way analysis of variance (ANOVA) were 
used to test for differences across genotype on demographic and psy-
chometric variables (Table 1). Differences related to sex and genotype 
on go/no- go task measures (hit rate, hit reaction time, false alarm 
rate, false alarm reaction time, and d’) were tested with a multivari-
ate analysis of variance (MANOVA; means and standard deviations 
in Table 2).
2.4.2 | Neuroimaging measures
Two- way ANOVAs (sex × genotype) were used to test main effects 
and the interaction of sex and genotype on brain activity, restricted to 
significant frontal and subcortical clusters from the one- sample t- tests 
of CRs versus FAs and CRs versus baseline (Table 3). Correction for test-
ing multiple comparisons was applied using the Benjamini–Hochberg 
false discovery rate (FDR) procedure (Benjamini & Hochberg, 1995; 
Q = .05, m = 8) for each of the three effects (i.e., main effect of geno-
type, main effect of sex, interaction of sex and genotype).
3  | RESULTS
3.1 | Psychometric variables
There were no significant genotype group differences, tested via 
one- way ANOVAs or Fisher’s exact tests, for participant sex (p = .940), 
age (p = .485), race3 (p = .124), parental history of AUD (ever: p = .377; 
in child’s lifetime: p = .883), IQ (p = .897), externalizing symptomology 
(p = .154), internalizing symptomology (p = .102), DSM- IV diagnoses 
(all ps = .476), or substance use (p = .554) (Table 1).
3.2 | Go/no- go task performance measures
Task performance measures (i.e., hit rate, false alarm rate, button 
press reaction times, d’; Table 2) were tested with a MANOVA with 
two factors (male vs. female; Met/Met vs. Val/Met vs. Val/Val). 
There was a significant effect of sex on task performance measures, 
F(5, 55)  = 2.53, p = .039; follow- up tests revealed a significant effect 
TABLE  3 Main effects of two go/no- go task contrasts and two- way ANOVA tests of genotype × sex
x y z k t- value
FWE 
p- value
Main Effect of 
Genotype F(2, 59)





R. Putamen 20 18 −2 131 6.40 .001 F = 5.83
p = .005a
partial η2 = .16
p = .259 F = 3.18
p = .049
partial η2 = .10
L. Putamen −14 16 −4 136 6.33 .001 F = 5.76
p = .005a 
partial η2 = .16
p = .976 p = .422
CRs vs. Baseline
B. Caudate 16 24 −6 789 7.90 <.001 p = .582 p = .245 F = 3.93
p = .025
partial η2 = .12
B. SMA/Mid Cingulate −6 10 42 1093 7.24 <.001 p = .164 p = .310 p = .108
L. Pre- /Postcentral Gyrus −60 2 22 142 6.07 .002 p = .084 p = .096 p = .404






partial η2 = .10
R. OFC 36 50 −12 60 6.00 .002 p = .374 p = .124 p = .118
R. IFG/Insula 46 14 −2 42 5.85 .004 F = 5.20
p = .008a 
partial η2 = .15
p = .363 p = .641
L, left; R, right; B, bilateral; k, cluster size; CR, correct rejection; FA, false alarm; SMA, supplementary motor area; IFG, inferior frontal gyrus; OFC, orbito-
frontal cortex; η, eta.
Coordinates are in Montreal Neurological Institute (MNI) space. Results (from SPM8) are significant at family- wise error rate (FWE) corrected p < .05 with 
a 25 voxel extent threshold; one peak voxel is reported per cluster.
aMain effects and/or interactions (from SPSS) significant at false discovery rate (FDR) corrected p < .05 (Benjamini–Hochberg procedure; Q = .05, m = 8). A 
measure of effect size (partial η2) is given for effects (from SPSS) significant at p < .05, uncorrected (in bold).
3See Supplemental Material for imaging analyses regarding race/ethnicity.
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of sex on false alarm rate, F(1, 59) = 9.81, p = .003 (males > females). 
There were also trend- level effects of sex on d’, F(1, 59) = 3.65, 
p = .061 (females > males) and hit reaction time, F(1, 59) = 3.12, 
p = .083 (females > males). There were no other significant effects.
3.3 | Imaging results
3.3.1 | Main effects of successful inhibition
CRs versus FAs
A one- sample t- test on the contrast of correct rejections (CRs) versus 
false alarms (FAs) showed significant activation in the right and left 
putamen (Fig. 1, Table 3).
CRs versus Baseline
The contrast of CRs versus baseline showed significant activation in 
several frontal and subcortical brain areas (Table 3). Specifically, sig-
nificant clusters were found the bilateral caudate, bilateral supple-
mentary motor area (SMA)/mid cingulate, left pre- /postcentral gyrus, 
left inferior frontal gyrus (IFG)/operculum, right orbitofrontal cortex 
(OFC), and right IFG/insula.
3.3.2 | Effects of sex, genotype, and sex × genotype
Two- way ANOVAs (sex × genotype) were performed in SPSS using 
significant clusters from the SPM one- sample t- tests of main effects 
of successful inhibition (Table 3). There was a significant main effect 
of genotype in right and left putamen (Fig. 1) and right IFG/insula 
(Fig. 2). These effects remained significant after controlling for testing 
multiple comparisons. Follow- up tests revealed that in both the left 
and right putamen, both Met/Met homozygotes and Val/Met hete-
rozygotes had significantly higher activity than Val/Val homozygotes. 
In right IFG/insula, Met/Met homozygotes had significantly higher ac-
tivity than Val/Val homozygotes.
There was also a main effect of sex in the left IFG/operculum and 
a sex by genotype interaction in the right putamen, bilateral caudate, 
and left IFG/operculum. However, these findings did not pass correc-
tion for multiple comparisons.
F IGURE  1 Correct Rejections versus False Alarms, Main Effect of Genotype. Whole- brain main effects analysis of correct rejections versus 
false alarms showed activation in left and right putamen. These regions are significant at a family- wise (FWE) corrected threshold of p < .05, 
with a 25 voxel extent. The color bar represents t- values and the y- coordinate is in Montreal Neurological Institute (MNI) space. Bar graphs 
depict significant main effects of genotype on mean cluster blood oxygenation level- dependent (BOLD) signal. Error bars are ± 1 standard error. 
L = left; R = right. Coordinates and statistics can be found in Table 3
F IGURE  2 Correct Rejections versus Baseline, Main Effect of Genotype. One cluster from the whole- brain main effects analysis of correct 
rejections versus baseline showed a significant main effect of genotype (right inferior frontal gyrus [IFG]/insula, circled). This region is significant 
at a family- wise (FWE) corrected threshold of p < .05, with a 25 voxel extent. The color bar represents t- values and the y- coordinate is in 
Montreal Neurological Institute (MNI) space. The bar graph depicts a significant main effect of genotype on mean cluster blood oxygenation 
level- dependent (BOLD) signal. Error bars are ± 1 standard error. Coordinates and statistics can be found in Table 3
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3.3.3 | Correlations with task performance measures
In the full sample, activity in the right OFC was significantly negatively 
correlated with hit rate, r(65) = −.25, p = .048 and d’, r(65) = −.28, 
p = .025. Activity in the right IFG/insula was also significantly nega-
tively correlated with d’, r(65) = −.26, p = .038. When testing cor-
relations in males and females separately, activity in three regions 
was significantly negatively correlated with hit rate in females but 
not in males: left IFG/operculum, r(22) = −.53, p = .010; right OFC, 
r(22) = −.46, p = .031; and right IFG/insula, r(22) = −.50, p = .019. Also 
in females, there was a significant negative correlation between d’ and 
activity in left IFG/operculum, r(22) = −.51, p = .016 as well as right 
IFG/insula, r(22) = −.44, p = .039. In males, there was a significant 
negative correlation between d’ and activity in right OFC, r(43) = −.34, 
p = .023.
4  | DISCUSSION
This study investigated the association between the COMT Val158Met 
polymorphism and neural activity during response inhibition in male 
and female youth at high- risk for SUD. During the successful inhibi-
tion of a prepotent motor response, a network of regions including 
the left and right putamen, bilateral caudate, and right IFG/insula were 
activated, consistent with prior reports of response inhibition circuitry 
(Buchsbaum, Greer, Chang, & Berman, 2005; Garavan, Ross, & Stein, 
1999; Simmonds, Pekar, & Mostofsky, 2008). Three regions activated 
during successful inhibition showed a significant main effect of geno-
type—left and right putamen and right IFG/insula—with Met/Met ho-
mozygotes having higher activity than Val/Val homozygotes, contrary 
to hypotheses that Val/Val homozygotes would show the highest lev-
els of brain activity. Also contrary to hypotheses that effects would be 
stronger in males, no significant interactions with sex were observed.
For the contrast of correct rejections versus false alarms (CRs vs. 
FAs), we found significant activation in the left and right putamen that 
was also significantly associated with COMT genotype. It has been 
suggested that greater activation of the putamen during successful 
compared with failed inhibition may reflect dopaminergic processes 
associated with trial- and- error learning (Holroyd & Coles, 2002; 
Stevens, Kiehl, Pearlson, & Calhoun, 2009). The right IFG/insula is a 
region classically associated with successful inhibitory control (e.g., 
Aron, Fletcher, Bullmore, Sahakian, & Robbins, 2003), and may act by 
exerting goal- directed influences consistent with executive control of 
behavior (Stevens, Kiehl, Pearlson, & Calhoun, 2007).
Despite the associations among mesolimbic dopamine, inhibitory 
control, and risk for SUD, the effects of the COMT Val158Met poly-
morphism on brain activation during response inhibition have not been 
examined in high- risk youth. The function of the COMT enzyme is to 
degrade dopamine, with the Met version of the polymorphism coding 
for the low activity enzyme and resulting in higher levels of dopamine. 
Our findings indicate that the highest BOLD activity during inhibitory 
control is exhibited by those with the highest dopamine levels (i.e., 
Met/Met homozygotes). Accordingly, lower levels of BOLD activity 
corresponded with lower levels of dopamine (Val/Val homozygotes). 
Considering there were no significant differences in task performance 
related to genotype, these findings can be interpreted as lower effi-
ciency during successful inhibition in Met/Met individuals relative 
to the Val/Val homozygotes, with Val/Met heterozygotes displaying 
intermediate levels of efficiency. It is important to note, however, 
that the interpretation of lower efficiency in Met/Met participants is 
not specific to any one underlying mechanism (see Poldrack, 2015). 
Potential biological processes that could explain differential activation 
in the context of similar task performance between groups include per-
forming different cognitive processes or neural computations. It is also 
possible that groups differ on neural computation intensity or timing.
The extant human and animal literature suggests that cognitive 
task performance and dopamine concentration follow an inverted 
U relationship (Arnsten & Goldman- Rakic, 1998; Bilder, Volavka, 
Lachman, & Grace, 2004; Mattay et al., 2003), with too little or too 
much dopamine resulting in reduced cognitive functioning. The nature 
of this association with regard to COMT is well- established in adults; it 
is the Met/Met genotype that lies at the top of the curve and is thus 
the optimal polymorphism (e.g., Egan et al., 2001). A study of healthy 
adult subjects in which the COMT enzyme was pharmacologically ma-
nipulated further supports this: Administration of tolcapone, a COMT 
enzyme inhibitor, improved executive functioning in subjects with 
the Val/Val genotype, but worsened performance in Met/Met sub-
jects (Apud et al., 2007). However, there is also substantial evidence 
this relationship is not static throughout development. Dopaminergic 
concentrations increase in early- to mid- adolescence before dropping 
throughout adulthood (reviewed in Spear, 2000), effectively shifting 
the location of the COMT genotypes on the inverted U from childhood 
to adolescence to adulthood (reviewed in Wahlstrom, Collins, White, 
& Luciana, 2010). Thus, the advantage belongs to Val/Met heterozy-
gotes during adolescence (Wahlstrom et al., 2007) and, as we found 
here, Val/Val homozygotes in late childhood.
Here we found that Val/Val subjects had reduced brain activity 
during successful inhibitory control in the absence of genotype- related 
task performance differences. Thinking more broadly about COMT 
and impulsivity in general, the literature—based primarily on adult 
samples—is not clear. Theoretically, the Val allele is thought to lead to 
weakened inhibitory control and a propensity to impulsivity by way of 
enhancing flexibility, whereas the Met allele is thought to enhance in-
hibitory control by dampening cortical noise (reviewed in Congdon & 
Canli, 2008). Boettiger et al. (2007) indeed found that Val/Val individu-
als demonstrated a more impulsive pattern of choice behavior than the 
other two genotypes on a temporal discounting task in healthy adults. 
On the other hand, also in a sample of healthy adults, Soeiro- de- Souza, 
Stanford, Bio, Machado- Vieira, and Moreno (2013) reported that the 
nonplanning impulsiveness factor of the Barratt Impulsiveness Scale- 11 
(Patton, Stanford, & Barratt, 1995) was higher in Met/Met subjects 
than in Val/Val subjects. Other studies have found this general pattern 
as well: DeYoung et al. (2010) and Biederman et al. (2008) both found 
that the Met allele was associated with ADHD symptoms. Finally, a re-
cent study of male children and adolescents found significantly higher 
hyperactive- impulsive and inattentive scores in Met/Met individuals 
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(Perkovic et al., 2013). Indeed, the relationship between COMT and im-
pulsivity is not clear- cut, but is nonetheless essential for understanding 
how genetic variation, behavior such as inhibitory control and impulsiv-
ity, brain function, and substance use problems are related.
Disinhibitory psychopathologies, including substance use prob-
lems, are often comorbid with other disorders. Thus, these findings 
may have broader implications in terms of risk for a variety of other 
psychopathologies as well. In adults, COMT has been associated with 
prefrontal functioning and executive control in schizophrenia (Ehlis, 
Reif, Herrmann, Lesch, & Fallgatter, 2007), social cognition in bipolar 
disorder (Soeiro- de- Souza et al., 2012), as well as risk for obsessive- 
compulsive disorder (Azzam & Mathews, 2003) and early onset major 
depressive disorder (Massat et al., 2005). As this study is part of a 
larger ongoing longitudinal project, it will be critical to follow these 
participants throughout their teens and twenties to examine links be-
tween the present results and the future development of disinhibitory 
and other psychopathologies, including substance use problems.
Contrary to recent work (White et al., 2014), we did not find 
significant sex × genotype interactions in brain regions associated 
with successful response inhibition after correcting for testing mul-
tiple comparisons. However, given the young age of the partici-
pants in this study (10.4 years) relative to those in the White et al. 
study (14.0 years), one possibility is that these interaction effects 
appear later in development, perhaps with the onset of puberty. 
Indeed, evidence suggests that estrogen may inhibit COMT activity 
(Schendzielorz, Rysa, Reenila, Raasmaja, & Mannisto, 2011; Xie, Ho, 
& Ramsden, 1999), an effect that may contribute to sex differences in 
COMT polymorphism effects in older samples. Another possibility is 
that given the limited distribution of participants across combinations 
of sex and genotype, our ability to detect sex × genotype interactions 
was artificially restricted. Future work in larger samples using a lon-
gitudinal design beginning in childhood and including measurement 
of hormonal concentrations will enable a more complete understand-
ing of sex differences in COMT polymorphism effects on inhibitory 
control.
Regarding task performance measures, we did find that males 
had more false alarms than females, indicating a more impulsive re-
sponding style or a greater difficulty inhibiting a prepotent response, 
even prior to adolescence. There is mixed support in the literature for 
males being more impulsive than females (e.g., Campbell & Muncer, 
2009). Those studies that have found sex differences related to impul-
sivity have focused primarily on risky or dangerous impulsivity rather 
than a more pure form that involves spontaneous action without the 
element of risk or danger. It is important to note here that the go/
no- go paradigm is not typically considered a measure of risky impul-
sivity. Still, these findings fit with the heightened prevalence of ADHD 
and other disinhibitory behavior in boys relative to girls (APA, 2000; 
Bauermeister et al., 2007). In the present sample, although just five 
of the eight participants diagnosed with ADHD were male, it is also 
possible that the heightened hyperactivity and impulsivity often seen 
in boys with ADHD relative to girls with ADHD (American Psychiatric 
Association, 2000; Gaub & Carlson, 1997; Hasson & Goldenring Fine, 
2012) played some role. These findings are also interesting in light of 
the fact that use of various substances has frequently been found to 
be higher in boys than girls (Johnston, O’Malley, Miech, Bachman, & 
Schulenberg, 2015; SAMHSA, 2014) (though recent trends suggest 
less disparity than before). Again, this highlights the importance of 
following these participants throughout development to better under-
stand the association between inhibitory control and later substance 
use.
We also found negative correlations between task measures 
and brain activity in the right OFC and IFG/insula in the full sample. 
Specifically, we found significant correlations with d’ (a measure of sen-
sitivity or discriminability) and hit rate, both of which reflect constructs 
that are distinct from inhibitory control. The correlations indicate that 
greater discriminability between go and no- go stimuli was associated 
with less activation in the OFC and IFG/insula. In light of the main 
effect of genotype in the IFG/insula, with Val/Val subjects showing the 
lowest levels of activity, the negative correlation between discrimin-
ability and IFG/insula activity may be further evidence of a cognitive 
advantage for Val/Val homozygotes in childhood. Future studies with 
more subjects may find significant task performance differences by 
genotype to confirm this preliminary interpretation.
To our knowledge, this is the first fMRI study to examine the ef-
fects of the COMT Val158Met polymorphism on brain activity during 
response inhibition in children at high- risk for SUD, but prior to their 
onset of significant substance use. The COMT Val158Met polymor-
phism was found to be associated with brain activity during response 
inhibition in high- risk children aged 7–12, with Val/Val individuals 
showing the lowest levels of brain activity in three regions. This adds 
to a growing body of literature suggesting the importance of genetic 
variation in COMT in cognitive control and extends it to include high- 
risk youth performing response inhibition. These results are also 
relevant for understanding how specific genes influence brain func-
tioning related to SUD and other psychopathologies. It will be import-
ant for follow- up studies to continue elucidating the pathway from 
dopamine- related genes such as COMT, to inhibition- related cognitive 
functioning, and finally to disinhibitory psychopathological outcomes, 
including substance abuse.
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